Close

<img data-src="https://vator.tv/wp-content/uploads/2024/10/Vator_News_Logos.png" data-srcset="https://vator.tv/wp-content/uploads/2024/10/Vator_News_Logos.png 1x, https://vator.tv/wp-content/uploads/2024/10/Vator_News_Logos.png 2x" alt="VatorNews" class="logo lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style="--smush-placeholder-width: 600px; --smush-placeholder-aspect-ratio: 600/200;" /><noscript><img src="https://vator.tv/wp-content/uploads/2024/10/Vator_News_Logos.png" srcset="https://vator.tv/wp-content/uploads/2024/10/Vator_News_Logos.png 1x, https://vator.tv/wp-content/uploads/2024/10/Vator_News_Logos.png 2x" alt="VatorNews" class="logo" />

Close

LifeSci

Steven Loeb
May 7, 2021

Clinical trial platform Science 37 is going public via a SPAC merger

One of big trends of 2021 has been the emergence of special-purpose acquisition companies. or SPACs, which act as Read More